Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | +2.17K | +28.75% | 9.71K | May 1, 2022 | Direct | F1 | ||
transaction | OGN | Common Stock | Tax liability | -$32.9K | -1.02K | -10.5% | $32.33 | 8.69K | May 1, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -2.17K | -50% | $0.00 | 2.17K | May 1, 2022 | Common Stock | 2.17K | Direct | F1 |
Id | Content |
---|---|
F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested with the remaining 50% of the RSUs to vest on May 1, 2023. |